Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
27.33
-0.12 (-0.44%)
Apr 29, 2026, 11:52 AM EDT - Market open
Neurogene Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 103.85 | 136.59 | 148.21 | 82.02 | 70.54 |
| Short-Term Investments | 165.17 | 175.82 | 48.95 | - | - |
| Cash & Short-Term Investments | 269.01 | 312.41 | 197.16 | 82.02 | 70.54 |
| Cash Growth | -13.89% | 58.45% | 140.37% | 16.27% | - |
| Other Receivables | 0.46 | 0.65 | 0.6 | 0.99 | 0.79 |
| Receivables | 0.46 | 0.65 | 0.6 | 0.99 | 0.79 |
| Prepaid Expenses | 1.94 | 1.89 | 1.5 | 1.08 | 1.91 |
| Other Current Assets | 0.36 | 0.98 | 1.1 | 0.63 | 0.71 |
| Total Current Assets | 271.77 | 315.92 | 200.35 | 84.72 | 73.96 |
| Property, Plant & Equipment | 15.46 | 18.49 | 20.95 | 24.55 | 27.53 |
| Other Long-Term Assets | 1.37 | 1.31 | 1.27 | - | - |
| Total Assets | 288.6 | 335.73 | 222.57 | 109.27 | 101.49 |
| Accounts Payable | 1.95 | 1.34 | 2.6 | 0.63 | 5.63 |
| Accrued Expenses | 10.19 | 9.39 | 16.76 | 5.16 | 4.35 |
| Current Portion of Leases | 3.06 | 3 | 2.6 | 0.7 | 0.61 |
| Other Current Liabilities | 1.2 | 1.43 | 1.02 | 0.17 | 0.27 |
| Total Current Liabilities | 16.41 | 15.16 | 22.97 | 6.65 | 10.86 |
| Long-Term Leases | 6.83 | 9.43 | 12.37 | 3.99 | 4.6 |
| Other Long-Term Liabilities | 0.48 | 0.77 | 1.21 | - | - |
| Total Liabilities | 23.72 | 25.36 | 36.55 | 10.64 | 15.46 |
| Common Stock | - | - | - | - | 0 |
| Additional Paid-In Capital | 617.54 | 572.67 | 373.18 | 5.1 | 3.77 |
| Retained Earnings | -352.65 | -262.3 | -187.15 | -150.84 | -95.65 |
| Total Common Equity | 264.89 | 310.38 | 186.02 | -145.74 | -91.88 |
| Shareholders' Equity | 264.89 | 310.38 | 186.02 | 98.63 | 86.03 |
| Total Liabilities & Equity | 288.6 | 335.73 | 222.57 | 109.27 | 101.49 |
| Total Debt | 9.89 | 12.43 | 14.97 | 4.69 | 5.21 |
| Net Cash (Debt) | 259.12 | 299.98 | 182.19 | 77.33 | 65.34 |
| Net Cash Growth | -13.62% | 64.65% | 135.59% | 18.36% | - |
| Net Cash Per Share | 12.15 | 17.08 | 39.12 | 196.01 | 16.13 |
| Filing Date Shares Outstanding | 15.57 | 14.93 | 12.85 | 5.67 | 4.05 |
| Total Common Shares Outstanding | 15.49 | 14.85 | 12.82 | 5.67 | 4.05 |
| Working Capital | 255.36 | 300.77 | 177.38 | 78.07 | 63.1 |
| Book Value Per Share | 17.10 | 20.89 | 14.51 | -25.72 | -22.68 |
| Tangible Book Value | 264.89 | 310.38 | 186.02 | -145.74 | -91.88 |
| Tangible Book Value Per Share | 17.10 | 20.89 | 14.51 | -25.72 | -22.68 |
| Machinery | 10.87 | 9.6 | 9.31 | 9.04 | 6.01 |
| Construction In Progress | 0.32 | 1.31 | 0.23 | 0.25 | 2.86 |
| Leasehold Improvements | 15.42 | 15.4 | 15.38 | 15.3 | 15.29 |
Source: S&P Capital IQ. Standard template. Financial Sources.